Vanadium: study protocols
4 study groups say how much Vanadium participants took a day. These are the doses the studies gave. They are not a recommendation.
Dose per serving from products
1,309 products in our catalogue print how much Vanadium a serving holds.
Most common: 5 mcg to 10 mcg, 30% of 1,309 products.
| Dose per serving | Products |
|---|---|
| 1 mcg or less | 10 |
| 1 mcg to 2.5 mcg | 65 |
| 2.5 mcg to 5 mcg | 44 |
| 5 mcg to 10 mcg | 389 |
| 10 mcg to 25 mcg | 154 |
| 25 mcg to 50 mcg | 207 |
| 50 mcg to 100 mcg | 148 |
| 100 mcg to 250 mcg | 119 |
| 250 mcg to 500 mcg | 35 |
| 500 mcg to 1 mg | 46 |
| 1 mg to 2.5 mg | 27 |
| over 2.5 mg | 65 |
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
None of these 4 study groups took Vanadium with anything else.
4 study groups
| Study | |||
|---|---|---|---|
| Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients 2013 · 100 mg V/day group · Adults with type 2 diabetes | 100 mg | 6 weeks | 8 |
| Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients 2013 · 50 mg V/day group · Adults with type 2 diabetes | 50 mg | 6 weeks | 5 |
| Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients 2013 · 25 mg V/day group · Adults with type 2 diabetes | 25 mg | 6 weeks | 3 |
| Insulin Receptor Substrates Regulation and Clinical Responses Following Vanadium-Enriched Yeast Supplementation in Obese Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2023 · VEY · Obese adults with type 2 diabetes; age and sex not specified | 900 mcg | 12 weeks | — |